Two of Australia's biggest pharmacy brands are joining forces to become a multi-billion-dollar pharmaceutical juggernaut. Here's why the competition watchdog gave the deal the all-clear.
As of fiscal year-end 2024, McKesson had a cash and cash equivalents balance of $4.6 billion with an outstanding debt balance of $5.6 billion. Roughly one third of its debt is due to mature over the ...
Looking to save on grocery prices? Then a restaurant supply store may be the place you should shop. These are some of the best items you can find for sale.
Cardinal's pharmaceutical and specialty solutions segment distributes branded, generic, and specialty drugs and over-the-counter healthcare and consumer products. Cardinal plays a central role in the ...